| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |